IL125701A - Azole compounds endowed with antimycotic activity for human and veterinary use - Google Patents

Azole compounds endowed with antimycotic activity for human and veterinary use

Info

Publication number
IL125701A
IL125701A IL12570197A IL12570197A IL125701A IL 125701 A IL125701 A IL 125701A IL 12570197 A IL12570197 A IL 12570197A IL 12570197 A IL12570197 A IL 12570197A IL 125701 A IL125701 A IL 125701A
Authority
IL
Israel
Prior art keywords
human
veterinary use
azole compounds
antimycotic activity
compounds endowed
Prior art date
Application number
IL12570197A
Other languages
English (en)
Other versions
IL125701A0 (en
Original Assignee
Zambon Spa
Isagro Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa, Isagro Spa filed Critical Zambon Spa
Publication of IL125701A0 publication Critical patent/IL125701A0/xx
Publication of IL125701A publication Critical patent/IL125701A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Devices For Medical Bathing And Washing (AREA)
IL12570197A 1996-02-28 1997-02-25 Azole compounds endowed with antimycotic activity for human and veterinary use IL125701A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000371A IT1283038B1 (it) 1996-02-28 1996-02-28 Composti azolici ad attivita' antimicotica per uso umano e veterinario
PCT/EP1997/000886 WO1997031903A1 (fr) 1996-02-28 1997-02-25 Composes azole ayant des proprietes antimycotiques utiles en medecine humaine et veterinaire

Publications (2)

Publication Number Publication Date
IL125701A0 IL125701A0 (en) 1999-04-11
IL125701A true IL125701A (en) 2003-11-23

Family

ID=11373418

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12570197A IL125701A (en) 1996-02-28 1997-02-25 Azole compounds endowed with antimycotic activity for human and veterinary use

Country Status (32)

Country Link
US (2) US5869512A (fr)
EP (1) EP0877739B1 (fr)
JP (1) JP2000505466A (fr)
KR (1) KR19990087363A (fr)
CN (1) CN1082050C (fr)
AP (1) AP9801328A0 (fr)
AT (1) ATE219066T1 (fr)
AU (1) AU713049B2 (fr)
BG (1) BG102711A (fr)
BR (1) BR9707773A (fr)
CA (1) CA2247390A1 (fr)
CZ (1) CZ291790B6 (fr)
DE (1) DE69713276T2 (fr)
DK (1) DK0877739T3 (fr)
EA (1) EA003189B1 (fr)
EE (1) EE03684B1 (fr)
ES (1) ES2176689T3 (fr)
GE (1) GEP20002091B (fr)
HU (1) HUP9900569A3 (fr)
IL (1) IL125701A (fr)
IT (1) IT1283038B1 (fr)
NO (1) NO983953L (fr)
NZ (1) NZ331919A (fr)
OA (1) OA10847A (fr)
PL (1) PL328582A1 (fr)
PT (1) PT877739E (fr)
SI (1) SI0877739T1 (fr)
SK (1) SK283391B6 (fr)
TR (1) TR199801688T2 (fr)
UA (1) UA55405C2 (fr)
WO (1) WO1997031903A1 (fr)
ZA (1) ZA971665B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296925B1 (it) * 1997-12-05 1999-08-03 Zambon Spa Procedimento per la preparazione di composti ad attivita' antimicotica
US6297115B1 (en) * 1998-11-06 2001-10-02 Advanced Micro Devices, Inc. Cmos processs with low thermal budget
US7271185B2 (en) 2002-02-15 2007-09-18 Mitsui Chemicals, Inc. Optically active azole derivative and process for producing the same
GB0222964D0 (en) 2002-10-03 2002-11-13 Unilever Plc Polymeric film for water soluble package

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187399B (en) * 1980-12-24 1985-12-28 Sumitomo Chemical Co Process for preparing imidazolyl-propanol derivatives
EP0061835B1 (fr) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Composés de triazole , procédé pour leur préparation, leur utilisation comme fongicides de plantes et leurs compositions fongicides
DE3271901D1 (en) * 1982-02-03 1986-08-07 Ici Plc Heterocyclic compounds useful as pesticides and processes for making them
US4505919A (en) * 1982-10-09 1985-03-19 Pfizer Inc. Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
AU572889B2 (en) * 1983-09-26 1988-05-19 Sumitomo Chemical Company, Limited 1,2,4 - triazolyl propanols
KR930004193B1 (ko) * 1984-10-02 1993-05-21 스미또모 세이야꾸 가부시끼가이샤 N-치환된 트리아졸 유도체의 제조방법
US5081138A (en) * 1986-12-17 1992-01-14 Merck Frosst Canada, Inc. 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
IT1198240B (it) * 1986-12-23 1988-12-21 Agrimont Spa Azolilderivati fungicidi
IT1232943B (it) * 1987-11-09 1992-03-10 Mini Ricerca Scient Tecnolog Azolilderivati fungicidi.
US5134152A (en) * 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
CA2031892C (fr) * 1989-12-25 2000-08-01 Minoru Tokizawa Derives du triazole
NO913302L (no) * 1990-08-26 1992-03-02 Sankyo Co Anti-fungale triazolderivater, samt fremstilling og anvendelse derav
GB9307924D0 (en) * 1993-04-16 1993-06-02 Zeneca Ltd Chrial synthesis
CA2145458A1 (fr) * 1994-03-28 1995-09-29 Hiroki Kodama Derive du triazole; methode de preparation et utilisation
IT1273509B (it) * 1995-04-07 1997-07-08 Zambon Spa Composti azolici ad attivita' antimicotica per uso umano e veterinario

Also Published As

Publication number Publication date
OA10847A (en) 2003-02-05
SK283391B6 (sk) 2003-07-01
CZ274898A3 (cs) 1999-01-13
EP0877739A1 (fr) 1998-11-18
CZ291790B6 (cs) 2003-05-14
HUP9900569A3 (en) 2001-07-30
TR199801688T2 (xx) 1998-11-23
US6103909A (en) 2000-08-15
BG102711A (bg) 1999-04-30
EA199800693A1 (ru) 1999-06-24
WO1997031903A1 (fr) 1997-09-04
PT877739E (pt) 2002-11-29
AU713049B2 (en) 1999-11-25
JP2000505466A (ja) 2000-05-09
SK116198A3 (en) 1999-02-11
ITMI960371A0 (fr) 1996-02-28
EP0877739B1 (fr) 2002-06-12
DE69713276T2 (de) 2003-03-06
IL125701A0 (en) 1999-04-11
EE9800261A (et) 1999-02-15
ZA971665B (en) 1997-08-29
DK0877739T3 (da) 2002-10-07
UA55405C2 (uk) 2003-04-15
KR19990087363A (ko) 1999-12-27
EA003189B1 (ru) 2003-02-27
CA2247390A1 (fr) 1997-09-04
DE69713276D1 (de) 2002-07-18
CN1082050C (zh) 2002-04-03
HUP9900569A1 (hu) 1999-06-28
CN1212685A (zh) 1999-03-31
GEP20002091B (en) 2000-05-10
NO983953D0 (no) 1998-08-27
AP9801328A0 (en) 1998-09-30
NO983953L (no) 1998-10-26
SI0877739T1 (en) 2002-12-31
PL328582A1 (en) 1999-02-01
ES2176689T3 (es) 2002-12-01
IT1283038B1 (it) 1998-04-07
ATE219066T1 (de) 2002-06-15
AU2092997A (en) 1997-09-16
NZ331919A (en) 1999-04-29
ITMI960371A1 (it) 1997-08-28
BR9707773A (pt) 2000-01-04
EE03684B1 (et) 2002-04-15
US5869512A (en) 1999-02-09

Similar Documents

Publication Publication Date Title
GB9518115D0 (en) Triazole derivatives and their use as therapeutic agents
IL126645A0 (en) Triazolyl mercaptides and their use as microbicides
EP0788489A4 (fr) Composes heterocycliques et leur utilisation
PL331465A1 (en) Novel compounds and agents for treating diseases associated with triptase activity
IL128144A0 (en) Benzamidine derivatives and their use as medicaments with an ltb4-antagonistic activity
IL129140A0 (en) Antimycotic gel with high active substance release
IL125701A0 (en) Azole compounds endowed with antimycotic activity for human and veterinary use
HK1011020A1 (en) Triazole derivatives with antimycotic action and intermediates
AP9701100A0 (en) Azole compounds with antimycotic activity for human and veterinary use
GB9824160D0 (en) Heterocyclic compounds and their therapeutic use
AU1911997A (en) Antimycotic ectoparasiticidal product - external use
GB9423267D0 (en) Compounding elements and use thereof
HK1044771A1 (zh) 雜環n-丙酮基苯甲酰胺以及它們作為殺菌劑的使用
PL328860A1 (en) Ensilage facilitating agent
GB9425336D0 (en) Veterinary treatments
GB9713240D0 (en) Heterocyclic compounds and their therapeutic use
GB9802074D0 (en) Animal feed and its use
GB9820768D0 (en) Heterocyclic compounds and their therapeutic use
ZA958962B (en) Heterocyclic compounds and their preparations and use
GB9423948D0 (en) Heterocyclic compounds, their preparation and their therapeutic use
GB9414350D0 (en) Heterocyclic compounds, their preparation and their therapeutic use
GB9415175D0 (en) Heterocyclic compounds, their preparation and their therapeutic use

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees